Remed Co.Ltd
Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells,… Read more
Remed Co.Ltd (302550) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.007x
Based on the latest financial reports, Remed Co.Ltd (302550) has a cash flow conversion efficiency ratio of -0.007x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-278.95 Million) by net assets (₩39.94 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Remed Co.Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Remed Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Remed Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Remed Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rhinebeck Bancorp Inc
NASDAQ:RBKB
|
0.016x |
|
CHANJET INFO.TECHN.-H-YC1
F:C7D
|
N/A |
|
Globex Mining Enterprises Inc
OTCQX:GLBXF
|
-0.028x |
|
Clal Insurance Enterprises Holdings Ltd
TA:CLIS
|
0.008x |
|
Forum Markets, Incorporated
NASDAQ:FRMM
|
-0.037x |
|
Annehem Fastigheter AB
ST:ANNE-B
|
0.011x |
|
Dusit Thani Freehold and Leasehold Real Estate Investment Trust
BK:DREIT
|
-0.001x |
|
RAUTE OY A EO 2
F:RAUA
|
N/A |
Annual Cash Flow Conversion Efficiency for Remed Co.Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of Remed Co.Ltd from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩40.25 Billion | ₩1.24 Billion | 0.031x | -72.79% |
| 2023-12-31 | ₩30.79 Billion | ₩3.50 Billion | 0.114x | -34.77% |
| 2022-12-31 | ₩29.92 Billion | ₩5.21 Billion | 0.174x | +230.28% |
| 2021-12-31 | ₩26.10 Billion | ₩-3.49 Billion | -0.134x | -227.93% |
| 2020-12-31 | ₩24.79 Billion | ₩2.59 Billion | 0.105x | -20.14% |
| 2019-12-31 | ₩24.62 Billion | ₩3.22 Billion | 0.131x | +550.48% |
| 2018-12-31 | ₩10.94 Billion | ₩-317.96 Million | -0.029x | -282.16% |
| 2017-12-31 | ₩4.19 Billion | ₩66.75 Million | 0.016x | -- |